MedPath

A clinical trial to study the effect of two drugs saptaparna bark and chirabilva bark in patients with Kitibha kushta (psoriasis)

Phase 2/3
Not yet recruiting
Conditions
Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: KITIBAH,
Registration Number
CTRI/2022/10/046834
Lead Sponsor
Dr.Vinoda Y Sidaraddi
Brief Summary

This study is a randomised open labeled comparative parallel group clinical trial.It involves comparing the efficacy of Saptaparna twak kashaya internally 48ml twice a day before food and saptaparna twak tail external application twice a day for 30 days with that of chirabilva twak kashaya and tail. In this study classical symptoms of Kitibha kushta, candle grease sign, auspitz sign and PASI scoring will be assessed on before treatment, during fallow up and after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Subjects who are willing to be a part of research work.
  • Subjects with chronicity not more than 2yrs.
  • Subjects with mild to moderate disease.
Exclusion Criteria
  • 1.subjects with Kitibha kushta having extracutaneous manifestations.
  • 2.subjects with other systematic disorders like DM,HTN,Asthama.
  • 3.pregnant women and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Classical symptoms of Kitibha kushtaBefore treatment -on 0th day | During fallow up -on every 15th days | After treatment -on 30th day
Secondary Outcome Measures
NameTimeMethod
Candle grease signAuspitz sign

Trial Locations

Locations (1)

Government Ayurveda medical college and hospital Bengaluru

🇮🇳

Bangalore, KARNATAKA, India

Government Ayurveda medical college and hospital Bengaluru
🇮🇳Bangalore, KARNATAKA, India
Dr Vinoda Y Sidaraddi
Principal investigator
8867839367
vinodasidaraddi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.